ENOV (Enovis) Valuation Rank


ENOV Enovis Corp ENOV
60 GF Score
Price $22.71
GF Value $49.60
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Enovis Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Enovis Valuation Rank Related Terms

ENOV
60GF Score
Enovis Corp ENOV
Valuation Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Enovis (ENOV) Overvalued in 2026?

Based on GuruFocus' analysis, Enovis stock appears to be undervalued. The current stock price of $22.71 is trading 54.2% below its estimated GF Value™ of $49.60. GuruFocus considers Enovis to be Possible Value Trap.

Key valuation signals for ENOV:

  • Valuation Rank:
  • GF Value™: $49.60 vs. price of $22.71 (54.2% below fair value)
  • GF Score™: 60/100 with 6 warning signs

No single metric tells the full story. See the ENOV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Enovis Business Description

Address 2711 Centerville Road, Suite 400, Wilmington, DE, USA, 19808
Enovis Corp is a medical technology manufacturer and distributor of medical devices used in reconstructive surgery, rehabilitation, pain management, and physical therapy. Its products support patient care from injury prevention through post-surgical or post-injury rehabilitation and treatment of degenerative conditions. The company's reportable segments include Prevention & Recovery and Reconstructive segments. The majority of revenueis derived from the Prevention & Recovery segment, which includes products that are used by orthopedic specialists, primary care physicians, physical therapists, chiropractors, athletic trainers and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformitiesand sports-related injuries.
60GF Score

Get the complete analysis for ENOV

Valuation Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$22.71
Price
$49.60
GF Value